From Donald Trump's visit to the WEF meeting in Davos to Swiss rules on how to cook lobsters, here are the stories from Switzerland that captured global attention over the last 12 months. 1) Hundreds protest in Zurich over Trump's visit to Davos In January, more than a thousand people protested in central Zurich against the planned arrival of US President Donald Trump in Switzerland for the World Economic Forum (WEF). It remains to be seen if the same will happen again when Trump returns to Davos next month. 2) Swiss cooks ordered to stun lobsters before boiling At the start of this year, the Swiss government ordered an end to the common culinary practice of throwing flailing lobsters into boiling water, ruling that they must be knocked out before they are killed – part of a wider overhaul of Swiss animal protection laws. 3) Tearful Federer wins Australian Open for 20th Slam title It's not a Grand Slam tournament if Roger Federer doesn't cry. Photo: AFP Tennis … [Read more...] about The Swiss stories that made international headlines in 2018
News international headlines
Updated 8:43 am CDT, Thursday, August 23, 2018 Cassie Semyon, 21, an intern for NBC News, runs from the courthouse with results outside of federal court as jury deliberations are announced in the trial of the former Donald Trump campaign chairman Paul Manafort in Alexandria, Va., Tuesday, Aug. 21, 2018. less Cassie Semyon, 21, an intern for NBC News, runs from the courthouse with results outside of federal court as jury deliberations are announced in the trial of the former Donald Trump campaign chairman Paul ... more Photo: Jacquelyn Martin, AP Photo: Jacquelyn Martin, AP Image 1 of / 1 Caption Close Image 1 of 1 Cassie Semyon, 21, an intern for NBC News, runs from the courthouse with results outside of federal court as jury deliberations are announced in the trial of the former Donald Trump campaign chairman Paul … [Read more...] about GoBlueDressGo: Sprinting intern competes to break news
News organizations rightly reported the numerous asterisks attached to a small mid-stage study of a potential Alzheimer’s treatment highlighted at this week’s Alzheimer’s Association International Conference. As some stories reported, the study was a Phase 2 trial that hasn’t been peer reviewed or published in a journal, in which the drug didn’t meet its primary goal of showing a benefit after 12 months of treatment. Also widely reported was that numerous similar attempts to clear amyloid plaques associated with Alzheimer’s have failed to pan out. That’s important since other experimental therapies have had encouraging early results but didn’t work in a Phase 3 trial. But the question remains: Why did this experimental drug — BAN2401 — attract an avalanche of news coverage? Headlines used words like “hopes,” “promise,” and “benefit.” But for consumers, at this point in time, it’s … [Read more...] about Many questions linger about this possible Alzheimer’s treatment. So why the avalanche of news coverage?
Monday, July 16, 2018 by: Mike Adams Tags: Censorship, deplatforming, discrimination, Facebook, First Amendment, free speech, freedom, Google, Liberty, Mike Adams, monopolies, shadow ban, society, tech giants, Twitter, YouTube (Natural News) This is a partial reprinting of “The Censorship Master Plan Decoded,” available at this link (PDF). The Censorship Master Plan Decoded (i.e. “The Adams Report”) The blueprint for how tech giants covertly silence online speech, and how America can fight back against corporate tech monopolists To fully grasp how news censorship is achieved, it’s crucial to understand the ways in which news consumers come into contact with news sources and information. The method of contact determines the most effective method of censorship, as you will see explained below. Direct URLs and Apps This is achieved when users open a web browser and directly enter the URL of the website they wish to visit (i.e. www.trump.news). This … [Read more...] about Decentralization and the structure of news consumption
June 19, 2018 Michael Joyce is a writer-producer with HealthNewsReview.org and tweets as @mlmjoyce Last week we reported on ‘One cancer patient’s dramatic response to immunotherapy…’ and highlighted what we thought was a lack of healthy skepticism in the extensive (and mostly fawning) news coverage. Most importantly we wanted to show that by highlighting the dramatic response of a single patient — without cautioning readers that just one dramatic response by no means justifies using words like “miraculous” or “unprecedented” — some reporters were running the very real risk of giving people false hope, or misleading them.” “But the problem here is that this single patient is actually part of a larger clinical trial,” said Vinay Prasad, MD, a cancer specialist at Oregon Health and Science University. “So this one amazing outcome is picked out of dozens or hundreds cases in the trial … we have no … [Read more...] about News outlets focus on one dramatic outcome. But did researchers omit data from hundreds in clinical trial?